Nurturing biotech ventures

.

The Incubator

A world of
world-class
support

Jumar is more than lab space – it’s a truly integrated approach to supporting your research translation efforts. Our unique physical environment and wraparound services are wholly designed around your needs as an early-stage or scaling biotech venture.

Startup-friendly facilities

Range of state-of-the-art wet-labs, specialised equipment, private office and co-working, all purposely designed for biotech startups needs as you grow.

  • 25 fully self-contained laboratories between 24m2 and 90m2

  • Labs enclosed in PC2 facility containing compressed air, vacuum, carbon dioxide, oxygen, nitrogen gen, and nitrogen high purity

  • Select labs also contain nitrogen, lab-grade water

  • Clean room space

  • Communal laboratory facilities, include media solutions preparation area, wash-up area, freezer bank, cold room and storages

  • Range of startup offices between 12m2 and 73m2

  • 40 x Co-working desks

.

Day-to-day coordination

Building a startup will keep you busy. Avoid the daily distractions of running an office and let us take care of it.

  • A dedicated on-site support team

  • Conference room and meeting spaces

  • Reception, printing, mail handling

  • Internet access

  • Cleaning

  • Shared kitchens

  • Preferential pricing on consumables

  • End of trip facilities

.

Jumar residents can access research platform technologies from our partners at academic rates, including:

University of Melbourne Platforms

• Biological Optical Microscopy Platform

• Ian Holmes Imaging Centre (Electron Microscopy)

• Mass Spectrometry & Proteomics Facility

• Metabolomics Australia

• Melbourne Bioinformatics

• Melbourne Bioresources

• Melbourne Histology Platform

• Melbourne Magnetic Resonance

• Melbourne Protein Characterisation

WEHI Platforms

• Advanced Optical and Electron Microscopy

• Histology

• Flow Cytometry

• Culture Media

• Bioresources

• Bioinformatics

• Protein Analysis

• Proteomics

• Genomics

• Metabolomics

• Magnetic Resonance

• Drug Screening

Located in a world-class biomedical precinct

Jumar is located on two floors within CSL’s new global corporate headquarters, and in the heart of world-leading Melbourne Biomedical Precinct. You’ll also have ready access to a wider community of biomedical talent and experts.

.

Entrepreneurship programs

From fundraising readiness to IP strategies and regulatory fundamentals. Take advantage of our curated program of regular events to gain knowledge and confidence to run successful biomed and biotech companies.

.

A vibrant community

Jumar serves as a vibrant hub for residents and the wider Australian biotech can be part of a unique community – ideal to unlock ideas, innovation and knowledge sharing.

We foster connections to a range of specialty academics, researchers, clinicians, industry advisors, potential investors and business service providers.

.

Meet

Jumar Residents

.

Australian Genome Research Facility (agrf) partners with the genomics community to make profound improvements to people’s lives by delivering a world-class, innovative, and integrated capability. Their mission is to empower Australia to be recognised for world-class innovation and leading edge genomics.

Learn more.

.

Arovella Therapeutics are developing an invariant natural killer T (iNKT) cell therapy platform licenced from Imperial College London to treat cancer. Their lead product is ALA-101, a CD19 targeting iNKT cell therapy to treat blood cancers. They are also developing therapies to treat gastric cancers, gastroesophageal junction cancers, and pancreatic Cancer.

Learn more

.

Biointelect is a leading strategic planning and commercialisation advisory firm for the life science sector. They enable the commercialisation of new therapies by helping clients to develop and drive integrated strategy, identify and evaluate new business opportunities and engage with the right partners.

Learn more

.

The Centre for Biomedical Excellence (CBE) represents Australia's leading consultants across the biopharmaceutical sector, providing strategic solutions, encouraging excellence and increasing efficiency for firms across the Asia Pacific.

Learn more.

.

Celleo contributes intelligent production systems for the manufacture of Cell & Gene Therapies, with the mission of enabling Cell & Gene Therapies to deliver population-level health outcomes.

Learn more

.

Denteric are developing therapies that will make the treatment of severe periodontal disease much less painful, more reliable and effective. Their first product is a therapy designed to neutralise and clear virulence factors produced by Porphyromonas gingivalis (Pg).

Learn more.

.

H3D's mission is to make custom-fit medical devices accessible for everyday people. They do this by providing B2B software to manufacturers/labs which unlocks rapid growth for their custom-fit businesses: Product #1 = AutoDesign, which automates CAD processes with AI and removes the need for highly skilled CAD technicians; Product #2 = Smartphone Scanning, which enables remote, non-intrusive capture of 3D digital impressions.

Learn more.

.

Immunosis are developing a pioneering diagnostic platform, with the aim to promptly identify immune dysfunctions, ensuring patients with immune deficiencies access crucial medications sooner. The proprietary genomic test analyses the patient’s own genetic information from a whole blood sample and generates a report for the treating clinician.

Learn more

.

Inosi Therapeutics are developing therapies to address fibrosis, a condition associated with many chronic diseases where tissue damage leads to scarring and a loss of organ function. Their research involves first in class novel inhibitors targeting a central pathway in fibrosis and inflammation.

Learn more

.

Medical Products Hub (MPH) is a reliable bulk wholesaler of Medical Supplies and Personal Protective Equipement (PPE) that provides a safe end-to-end solution for clients seeking: bulk purchase of Personal Protective Equipment (PPE), other medical supplies and safety products.

Learn more

.

Nutromic's breakthrough technology involves a patch consisting of DNA-based sensors coated onto the tips of microneedles that unlocks continuous and real-time monitoring of multiple clinically relevant targets for some of the deadliest disease states in the world.

Learn more

.

Novoroo develops new therapeutic approaches to address neurological damage or disease in the central nervous system (CNS). Our novel LRP-focused science enables hope for treatment of conditions for which no current therapies exist.

Learn more

.

Pacalis Therapeutics utilises intellectual property developed at Monash University to drive advancements in drug discovery. Their focus lies in developing a targeted agonist specifically designed for the serotonin receptor, with the aim of revolutionising the treatment of mental health conditions such as depression and PTSD.

.

PolyActiva is an innovative clinical-stage ophthalmology company with a unique proprietary polymeric prodrug technology that enables site-specific, precise and controlled drug delivery to the eye. Their mission is to become a leader in ophthalmic medicine by providing unique biodegradable implants with sustained drug delivery to improve patient outcomes and quality of life.

Learn more

.

Qankorey are researching key technologies in prevention, screening, diagnosis and treatment of Alzheimer's disease. Their first product is a screening device that detects the risk of dementia and Alzheimer's disease. It is used to evaluate brain health status and assist doctors to decide whether further tests are required.

Learn more

.

RAGE Biotech is developing novel therapeutics targeting the Receptor for Advanced Glycation End-products (RAGE) for patients with difficult-to-treat inflammatory disease. Their most advanced programme is an inhaled drug for lung diseases where chronic inflammation is a driver.

Learn more

.

Symex Labs are building an innovative bio-sensor patch that can continuously track ovulation using hormone sensing in order to bring real independence and reliable insights about women's fertility.

Learn more.

.

Systematic Medicine's mission is to identify novel targets and therapeutic strategies to modulate the root causes of the ageing process.

Learn more

.

Tessara Therapeutics are working on a technology called RealBrain®, which is based on 3D neural micro-tissues that mimic the human brain. RealBrain® is the first 3D neural model to combine all the essential requirements for drug discovery, including dense & heterogeneous neural networks, compatibility with high-throughput automation, short generation time, and high optical clarity.

Learn more

.

Titan is a Contract Research Organisation (CRO). They assist biopharmaceutical clients in a range of activities from specific bid development to clinical protocol design to end-to-end clinical trials management, regulatory submission, and clinical implementation.

Learn more.

.

23Strands has developed a proven capability to deliver genome-wide DNA sequencing data to allow a more accurate understanding of complex diseases and to facilitate improvements in patient care. They are dedicated to utilising whole genome sequencing and Artificial Intelligence to unlock the power of your genetic code.

Learn more

Make an enquiry

Become a
Jumar resident

.

Be in a place that brings together the full range of support you need to take your discovery to the next stage of development.

To find out more about becoming a Jumar resident, including eligibility and selection criteria, complete the form below and we’ll be in touch.

Contact Us